IXHL - Incannex Healthcare Limited

1.27
0.030   2.362%

Share volume: 27,841
Last Updated: 02-28-2025

PREVIOUS CLOSE
CHG
CHG%
$1.24
-0.10
-0.07%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
-72.21%
Key data
Stock price
$1.27
P/E Ratio 
0.00
DAY RANGE
$1.24 - $1.37
EPS 
-$1.33
52 WEEK RANGE
N/A - N/A
52 WEEK CHANGE
N/A
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
17.643 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
1.17
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Joel Bradley Latham
Region: US
Website: www.incannex.com
Employees: 0
IPO year: 2023
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

Incannex Healthcare Inc., a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. Incannex Healthcare Inc. was incorporated in 2001 and is based in Sydney, Australia.

Recent news